Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Post-Marketing Commitments To Be Studied Under FDA Contract

This article was originally published in The Pink Sheet Daily

Executive Summary

Study will examine consistency of processes for designing and implementing Phase IV trials within and between FDA divisions, Deputy Commissioner Gottlieb says.

You may also be interested in...



FDA Awards Contract To Study Internal Post-Marketing Commitment Decision-Making

The agency said that it does not expect results from the evaluation to affect ongoing Phase IV studies.

FDA Awards Contract To Study Internal Post-Marketing Commitment Decision-Making

The agency said that it does not expect results from the evaluation to affect ongoing Phase IV studies.

Phase IV Commitments Proceed According To Schedule, FDA Says

FDA releases tally of postmarketing commitments for FY 2005 in annual report.

Related Content

Topics

UsernamePublicRestriction

Register

PS063800

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel